Nasdaq stss.
US82003F1012. Sharps Technology, Inc. is a medical device and pharmaceutical packaging company, which engages in the development and manufacturing of innovative drug delivery systems. It also focuses on low waste, and ultra-low waste syringe technologies that incorporate both passive and active safety features.
Nasdaq News: This is the News-site for the company Nasdaq on Markets Insider Indices Commodities Currencies StocksSharps Technology, Inc. (the “Company”) (NASDAQ: “STSS” and “STSSW”), an innovative medical device and pharmaceutical packaging company offering patented, best-in-class syringe products, and Nephron Pharmaceuticals Corporation, (“Nephron”) a privately owned U.S. leader in contract manufacturing and 503B outsourcing, announce the signing of an Asset Purchase Agreement (APA) to ...STSS Sharps Technology Inc Sharps Technology Appoints Industry Sales and Manufacturing Leader Ben Scheu as Senior Director of SalesNov 30, 2023 · Sharps Technology Announces $5.6 Million Registered Direct and Private Placement Priced at the Market Under Nasdaq Rules. NEW YORK, Sept. 27, 2023 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (the “Company”) (NASDAQ: “STSS” and “STSSW”), an innovative medical device and pharmaceutical packaging company offering patented, ... NEW YORK, Sept. 29, 2023 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (the “Company”) (NASDAQ: “STSS” and “STSSW”), an innovative medical device and pharmaceutical packaging company ...
Find the latest SEC Filings data for Sharps Technology Inc. Common Stock (STSS) at Nasdaq.com.
Stock Screener Earnings Calendar Sectors Nasdaq | STSS U.S.: Nasdaq Sharps Technology Inc. Watch list NEW Set a price target alert After Hours Last Updated: Nov …
Maybe you’ve never invested before. Maybe you have no clue what the difference is between NASDAQ and the New York Stock Exchange. Regardless, the name Charles Schwab probably rings a bell.NEW YORK, Jan. 10, 2023 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (the “Company”, "Sharps") (NASDAQ: “STSS” and “STSSW”), an innovative medical device and drug delivery Company ...NEW YORK, Sept. 29, 2023 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (the “Company”) (NASDAQ: “STSS” and “STSSW”), an innovative medical device and pharmaceutical packaging company ...Jan 13, 2023 · NASDAQ, Inc. short interest is available by issuer for the past 12 months and updated twice a month. Short interest data is reported on mid-month and end-of-month settlement dates. It is then ...
Find the latest news headlines from Sharps Technology Inc. Common Stock (STSS) at Nasdaq.com.
September 27, 2023 - 9:14 am. NEW YORK, Sept. 27, 2023 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (the “Company”) (NASDAQ: “STSS” and “STSSW”), an innovative medical device and pharmaceutical packaging company offering patented, best-in-class syringe products, today announced that it has entered into a definitive agreement with institutional investors for the purchase and sale of ...
Dave Gentry. RedChip Companies Inc. 1-800-RED-CHIP (733-2447) Or 407-491-4498. [email protected]. First product shipped from Sharps' facility in Hungary and first to support the Nephron ...RedChip Companies will air new interviews with Sharps Technology, Inc. (NASDAQ:STSS; STSSW) and BullFrog AI Holdings, Inc. (NASDAQ:BFRG; BFRGW) on The RedChip Money Report® on Bloomberg TV, this ...NEW YORK, April 04, 2023 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (the “Company”) (NASDAQ: “STSS” and “STSSW”), an innovative medical device and drug delivery Company offering ...NEW YORK, Feb. 06, 2023 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (the “Company”, "Sharps") (NASDAQ: “STSS” and “STSSW”), an innovative medical device and drug delivery Company ...NEW YORK, NY - (NewMediaWire) - September 22, 2023 - Sharps Technology, Inc. (NASDAQ: STSS), is pleased to announce its CEO, Robert Hayes, recently conducted an interview with SmallCapsDaily ...Nov 24, 2023 · STSS Sharps Technology Inc Current Report Filing (8-k) 0001737995 false 0001737995 2023-02-01 2023-02-01 0001737995 STS... RedChip Companies will air new interviews with Sharps Technology, Inc. (NASDAQ:STSS; STSSW) and BullFrog AI Holdings, Inc. (NASDAQ:BFRG; BFRGW) on The RedChip Money Report® on Bloomberg TV, this ...
NEW YORK, Dec. 20, 2022 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (the “Company”, "Sharps") (NASDAQ: “STSS” and “STSSW”), an innovative medical device and drug delivery Company ...NEW YORK and WEST COLUMBIA, S.C., Sept. 26, 2023 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (the “Company”) (NASDAQ: “STSS” and “STSSW”), an innovative medical device and ...Sharps Technology, Inc. (NASDAQ:STSS Free Report) saw a large decline in short interest in the month of June. As of June 15th, there was short interest totalling 171,000 shares, a decline of 47.6% from the May 31st total of 326,600 shares. Based on an average daily volume of 937,100 shares, the ... NEW YORK, Feb. 01, 2023 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (the “Company”, "Sharps") (NASDAQ: “STSS” and “STSSW”), an innovative medical device and drug delivery Company ...NEW YORK, Feb. 06, 2023 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (the “Company”, "Sharps") (NASDAQ: “STSS” and “STSSW”), an innovative medical device and drug delivery Company ...Find the latest Financials data for Sharps Technology Inc. Common Stock (STSS) at Nasdaq.com.The common stock and warrants began trading on The Nasdaq Capital Market on April 14, 2022, under the symbols “STSS” and “STSSW,” respectively. Aegis Capital Corp. acted as the sole book ...
NASDAQ: STSS - Sharps Technology: Archive Watch Replay: Tuesday October 3, 2023 4:15 PM ET: NASDAQ: SPI - SPI Energy: Archive Watch Replay: September 2023: Thursday September 21, 2023 4:15 PM ET: NYSE AMERICAN: SBEV - Splash Beverage Group: Archive Watch Replay: Wednesday September 20, 2023 4:15 PM ET: NASDAQ: RVPH - Reviva Pharmaceuticals ...At Cannae Holdings, a filing with the SEC revealed that on Monday, Director Barry B. Moullet bought 1,000 shares of CNNE, for a cost of $23.06 each, for a total investment of $23,064. So far ...
On Invalid Date, Sharps Technology (NASDAQ: STSS) reported Q2 2023 earnings per share (EPS) of -$0.22, up 466.67% year over year. Total Sharps Technology earnings for the quarter were -$2.61 million. In the same quarter last year, Sharps Technology's earnings per share (EPS) was $0.06.STSS Sharps Technology Inc Current Report Filing (8-k) 0001737995 false 0001737995 2023-02-01 2023-02-01 0001737995 STS...RedChip Companies, a renowned international investor relations firm specializing in microcap and small-cap companies,announce the launch of its much-anticipated podcast series, "Small Stocks, Big ...NASDAQ: STSS - Sharps Technology: Archive Watch Replay: Tuesday October 3, 2023 4:15 PM ET: NASDAQ: SPI - SPI Energy: Archive Watch Replay: September 2023: Thursday September 21, 2023 4:15 PM ET: NYSE AMERICAN: SBEV - Splash Beverage Group: Archive Watch Replay: Wednesday September 20, 2023 4:15 PM ET: NASDAQ: RVPH - Reviva Pharmaceuticals ...Sharps Technology has extensive expertise in specialized prefilled syringe systems and ready to use processing. The company has a manufacturing facility in Hungary and has partnered with Nephron ...STSS Sharps Technology Inc. 0.80-0.0099 (-1.22%) After Hours. Last Updated: 17:40:18. Delayed by 15 minutes ...STSS: Get the latest Sharps Technology stock price and detailed information including STSS news, historical charts and realtime prices. Gainers Unique Fabricating, Inc. (NYSE: UFAB) climbed 205% to $0.55 after gaining around 4% on Tuesday. ...On October 5, 2023, Sharps Technology Inc. (NASDAQ: STSS) made a significant move by venturing into the copolymer prefillable syringe market.This strategic decision was made possible through a partnership with Nephron Pharmaceuticals Corp., a renowned player in generic medication contract manufacturing and 503B outsourcing, particularly in the …
Dave Gentry. RedChip Companies Inc. 1-800-RED-CHIP (733-2447) Or 407-491-4498. [email protected]. First product shipped from Sharps' facility in Hungary and first to support the Nephron ...
Sharps Technology Inc. (NASDAQ: STSS) has recently made significant strides in the copolymer prefillable syringe market, thanks to a strategic partnership with Nephron Pharmaceuticals Corp. Nephron Pharmaceuticals Corp., a renowned player in contract manufacturing of generic medications and 503B outsourcing, has agreed to a …
Find the latest SEC Filings data for Sharps Technology Inc. Common Stock (STSS) at Nasdaq.com. If you’re familiar with investing, then you’ve probably heard of major stock exchanges like the New York Stock Exchange or the NASDAQ. Stock exchanges are sort of like a mixture between an auction house and a marketplace where investors can...NEW YORK, NY / ACCESSWIRE / April 19, 2022 / Aegis Capital Corp. acted as Sole Bookrunner on a ~$16 Million Initial Public Offering for Sharps Technology, Inc. (NASDAQ:STSS). About Sharps ...10-Year Purchase Agreement: As a result of the proposed acquisition of InjectEZ, Nephron has agreed to a 10-year Purchase Agreement for Sharps’ next-generation copolymer prefillable 10 mL and 50 ...According to NASDAQ, as of May 2014, the highest NASDAQ closing ever was achieved on March 9, 2000, when the market closed at a record 5046.86. USA Today reports that the highest closing achieved by NASDAQ since was a 4007.09 closing on Nov...NEW YORK, April 04, 2023 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (the “Company”) (NASDAQ: “STSS” and “STSSW”), an innovative medical device and drug delivery Company offering ...Sharps Technology Inc. Common Stock (STSS) Advanced Charting - Nasdaq offers advanced charting & market activity data for US and global markets. NEW YORK, Sept. 28, 2023 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (the “Company”) (NASDAQ: “STSS” and “STSSW”), an innovative medical device and drug delivery Company offering ...
See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. STSS's current price target is $0.00. Learn why top analysts are making this stock forecast for Sharps Technology at MarketBeat.Item 3.01. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.. On July 12, 2023, Sharps Technology, Inc. (the “Company”) received a notice (the “Notice”) from the staff of the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that it was not in compliance with Nasdaq ...Usually, when one insider buys stock, it might not be a monumental event. But when multiple insiders are buying like they did in the case of Sharps Technology, Inc. (NASDAQ:STSS), that sends out a ...Instagram:https://instagram. heritage sports auctionstop financial magazinesinnovation refunds erc reviewsmishx Nov 17, 2023 · Sharps Technology, Inc. (the “Company”) (NASDAQ: “STSS” and “STSSW”), an innovative medical device and drug delivery Company offering patented, best-in-class syringe products, announces an update on commercialization activities and is highlighted in Med Tech Outlook feature article. penny stocks to watch tomorrowfuture trading broker NEW YORK, Feb. 01, 2023 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (the “Company”, "Sharps") (NASDAQ: “STSS” and “STSSW”), an innovative medical device and drug delivery Company ... psec Settings. from pyfmpcloud import settings. General helper functions to access and update settings for the library environment. These are: set_apikey: Please set your API Key in this file using the settings.set_apikey ( [YOUR KEY]). The key can be retrieved from fmpcloud.io by signing up. Default is the 'demo' key.Nike, Inc. has no single specific owner. According to Nasdaq, the company is a publicly traded one, with its shares listed on the New York Stock Exchange under the symbol NKE. As of May, 2014, 83.29 percent of Nike’s shares were owned by in...WEST COLUMBIA, S.C. and NEW YORK, Nov. 10, 2022 (GLOBE NEWSWIRE) -- Nephron Pharmaceuticals Corporation and Sharps Technology, Inc. (the “Company”) (NASDAQ: “STSS” and “STSSW”), an innovative medical device and drug delivery company offering patented, best-in-class syringe products, announced today a …